Page last updated: 2024-10-24

chlorambucil and Cyclitis, Heterochromic

chlorambucil has been researched along with Cyclitis, Heterochromic in 1 studies

Chlorambucil: A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed)
chlorambucil : A monocarboxylic acid that is butanoic acid substituted at position 4 by a 4-[bis(2-chloroethyl)amino]phenyl group. A chemotherapy drug that can be used in combination with the antibody obinutuzumab for the treatment of chronic lymphocytic leukemia.

Research Excerpts

ExcerptRelevanceReference
"Chlorambucil was found to be a very potent drug for JCA with acceptable short term, but serious longterm side effects."6.69Chlorambucil in severe juvenile chronic arthritis: longterm followup with special reference to amyloidosis. ( Savolainen, HA, 1999)
"Chlorambucil was found to be a very potent drug for JCA with acceptable short term, but serious longterm side effects."2.69Chlorambucil in severe juvenile chronic arthritis: longterm followup with special reference to amyloidosis. ( Savolainen, HA, 1999)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Savolainen, HA1

Trials

1 trial available for chlorambucil and Cyclitis, Heterochromic

ArticleYear
Chlorambucil in severe juvenile chronic arthritis: longterm followup with special reference to amyloidosis.
    The Journal of rheumatology, 1999, Volume: 26, Issue:4

    Topics: Adolescent; Amyloidosis; Antineoplastic Agents, Alkylating; Arthritis, Juvenile; Child; Child, Presc

1999